Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,911
Total Claims
$1.2M
Drug Cost
614
Beneficiaries
$1,927
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-93%
Opioid rate vs peers
0.2% vs 2.2% avg
+37%
Cost per patient vs peers
$1,927 vs $1,411 avg
+56%
Brand preference vs peers
16.6% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
20
Opioid Claims
$340
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,132 claims · $834K
Generic: 10,694 claims · $348K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 504 | $164K |
| Valbenazine Tosylate | 13 | $96K |
| Bictegrav/Emtricit/Tenofov Ala | 12 | $48K |
| Rivaroxaban | 136 | $39K |
| Daptomycin | 15 | $32K |
| Sitagliptin Phosphate | 66 | $27K |
| Rifaximin | 17 | $25K |
| Sacubitril/Valsartan | 35 | $20K |
| Vibegron | 76 | $19K |
| Insulin Aspart | 104 | $17K |
| Epoetin Alfa | 24 | $15K |
| Dapagliflozin Propanediol | 29 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 89 | $14K |
| Umeclidinium Brm/Vilanterol Tr | 27 | $13K |
| Sevelamer Carbonate | 41 | $13K |
Prescribing Profile
Patient Profile
74
Avg Age
50%
Female
3.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data